Delivery Order 75F40120D00032-75F40125F19010
Award Date 5/14/25
Potential Completion Date 11/13/26
Potential Value $75K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Two Step
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration (FDA) awarded a delivery order valued at $300,000 to We Pharma, Inc., doing business as WEP Clinical, for the provision of pharmaceutical drug products to support FDA research studies. The contract, which is firm fixed price with no set-aside designation, carries an ultimate completion date of September 16, 2026, and will be performed at the FDA's Takoma Park, Maryland location. We Pharma, a self-certified small disadvantaged business and limited liability...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to We Pharma, Inc., a self-certified small disadvantaged business structured as a limited liability company. The contract, valued at $357,000.00, is for the provision of pharmaceutical drug products to support the FDA's various research, regulatory, and emergency response activities. We Pharma, doing business as WEP Clinical, holds two significant Indefinite Delivery Contracts (IDCs) with the FDA, totaling $9.5 million...
- This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services, to We Pharma, Inc., a self-certified small disadvantaged business. The $214,914.90 contract is for the provision of "PHYSICOCHEMICAL PRODUCTS" and has a total small business set-aside. The award supports the FDA's regulatory science program and provides pharmaceutical drug products for the agency's research, compliance, and...
- This delivery order against the Department of Health and Human Services Food and Drug Administration is for the purpose of obtaining currently marketed drug products for FDA research studies. Awarded on September 30, 2020 to We Pharma, Inc. located in Morrisville, North Carolina, this firm fixed price contract has a potential value of $246,754.22 and period of performance through September 29, 2021. No set-aside designation was applied. We Pharma Inc. will provide the requested drug products...
- The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
- The U.S. Food and Drug Administration (FDA) has awarded a $4,481,143.91 Delivery Order contract to Agisol LLC, an 8(a) certified small disadvantaged business, for CDER Streamline Process and Enhance Functions for New Drug Review. This is a Time and Materials contract awarded under the GSA Multiple Award Schedule (MAS) vehicle. Agisol LLC is a small IT services provider that specializes in supporting the FDA's regulatory review and research activities, including work on systems like the...
- The Department of Health and Human Services Food and Drug Administration awarded a $2.4 million firm fixed price delivery order to Paragon Micro Inc. under the Solutions for Enterprise Wide Procurement V government-wide acquisition contract. The order is for Symantec maintenance and technical support services to be performed in Silver Spring, Maryland through March 2021. As the FDA regulates food, drugs, medical devices and cosmetics, this order will likely provide ongoing software licensing,...
- This is a $238,597.26 firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Data Federal Corporation, a minority-owned, small disadvantaged business, for the Freedom Application for Shelf-Life Extension Program (SLEP) under the Division of Product Quality Research (DPQR). The contract is part of the FDA's civilian agency programs and has a period of performance through September 4, 2028. This delivery order was placed under Data Federal's existing Multiple Award...
- The Department of Health and Human Services' Food and Drug Administration awarded a $663,035 delivery order to 4 Star Technologies Inc. under the Solutions for Enterprise Wide Procurement V government-wide acquisition contract vehicle. The order is for Centrify products to support the agency's IT security programs in Rockville, Maryland. As the FDA works to ensure the safety of medical products and protect public health, this contract will provide the identity and access management solutions...
- The federal contract award described is for the delivery of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is a $1,745.88 firm fixed-price delivery...